Memorial Sloan Kettering Researchers Present Notable Research at 2019 American Society of Hematology Annual Meeting

Share
Print
MSK’s Martin Tallman speaks with his colleagues who treat blood-related cancers.

MSK’s Martin Tallman speaks with his colleagues who treat blood-related cancers.

Thousands of hematology-oncology professionals from around the world will gather in Orlando, Florida, from December 7 through 10 for the 61st American Society of Hematology (ASH) Annual Meeting and Exposition. The ASH Annual Meeting and Exposition is the world’s most comprehensive hematology event of the year.

Featuring new insights and important discoveries, this scientific forum will include presentations and data that could affect the way cancer care is planned and delivered in the hematology field. Memorial Sloan Kettering experts are involved in notable research presented at the meeting and are available to comment on the topics and themes of this year’s meeting. MSK experts Marcel van den Brink, Ola Landgren, Anthony Mato, Steven Horwitz, Sergio Giralt, Anas Younes, Miguel Angel Perales, Martin Tallman, and many other MSK clinicians and researchers are available for comment on their research and other studies presented at the meeting.   

MSK experts in CAR T cell therapy, CRISPR, immunotherapy, leukemia, lymphoma, and blood and marrow stem cell transplantation are also available to comment on meeting news. Follow the meeting live on Twitter using the hashtag #ASH19. For more information and to set up interviews or access photos and video, email Rebecca Williams at mediastaff@mskcc.org.